PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 215 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $8,000 | 0.0% | 2,244 | -4.3% | 0.01% | +25.0% |
| Q1 2016 | $8,000 | -52.9% | 2,344 | -28.7% | 0.00% | -78.9% |
| Q3 2015 | $17,000 | -100.0% | 3,286 | -73.8% | 0.02% | -68.9% |
| Q2 2014 | $121,522,000 | +13.8% | 12,554 | -2.3% | 0.06% | +24.5% |
| Q1 2014 | $106,775,000 | +71561.1% | 12,849 | -27.7% | 0.05% | -40.2% |
| Q4 2013 | $149,000 | – | 17,762 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |